Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC7A5 | Q01650 | 2/20 | 0.38 |
| ▸ | NOS2 | P35228 | 2/20 | 0.37 |
| ▸ | NOS3 | P29474 | 1/20 | 0.37 |
| ▸ | NOS1 | P29475 | 1/20 | 0.37 |
| ▸ | GRIK1 | P39086 | 2/20 | 0.35 |
| ▸ | SLC1A2 | P43004 | 5/20 | 0.33 |
| ▸ | SLC1A1 | P43005 | 5/20 | 0.33 |
| ▸ | SLC1A3 | P43003 | 4/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | GAA | P10253 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.33 |
| ▸ | SLC7A11 | Q9UPY5 | 1/20 | 0.33 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.33 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.33 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.33 |
| ▸ | KIF11 | P52732 | 1/20 | 0.32 |
| ▸ | GRIK2 | Q13002 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15372363 | 1.00 | SLC7A5 (0.38) | SLC7A5NOS2NOS3NOS1GRIK1 | |
| SCHEMBL1456149 | 0.81 | HDAC6 (0.38) | NOS2NOS3NOS1HDAC1HDAC2 | |
| SCHEMBL20033588 | 0.81 | HDAC6 (0.38) | NOS2NOS3NOS1HDAC1HDAC2 | |
| SCHEMBL10473405 | 0.80 | MEN1 (0.34) | MEN1GAAKMT2AHDAC1HDAC2 | |
| SCHEMBL8280474 | 0.80 | DPP4 (0.35) | HDAC1HDAC2HDAC6 | |
| SCHEMBL17898137 | 0.80 | MEN1 (0.34) | MEN1GAAKMT2AHDAC1HDAC2 | |
| SCHEMBL14750621 | 0.80 | MEN1 (0.34) | MEN1GAAKMT2AHDAC1HDAC2 | |
| SCHEMBL10562696 | 0.79 | SLC7A5 (0.37) | SLC7A5GRIK1SLC1A2SLC1A1SLC1A3 | |
| SCHEMBL12540999 | 0.79 | NOS2 (0.53) | NOS2NOS3NOS1GRIK1SLC1A2 | |
| SCHEMBL12541003 | 0.79 | NOS2 (0.53) | NOS2NOS3NOS1GRIK1SLC1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11730819-B2 | Peptide derivatives having novel linkage structures | BICYCLETX LIMITED (GB) | 2023-08-22 | — | — | US | disclosed |
| US-20220194983-A1 | PEPTIDE LIGANDS FOR BINDING TO PSMA | BICYCLETX LIMITED (GB) | 2022-06-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11730819-B2 | Peptide derivatives having novel linkage structures | DNPEP, LNPEP, ANPEP | SLC7A5 135/4885NOS2 3640/4885NOS3 2628/4885 |
| US-20220194983-A1 | PEPTIDE LIGANDS FOR BINDING TO PSMA | DNPEP, LNPEP, ANPEP | SLC7A5 723/4885NOS2 3908/4885NOS3 3363/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.